Cryoablation for liver cancer.

Primary cancer of the liver (hepatocellular carcinoma [HCC]) and metastatic cancer to the liver from a distant primary site of origin are very common problems in the United States and the world. The management of these diseases has become progressively complex as the available treatment options have improved and propagated. One option that has been gaining acceptance is image-guided tumor ablation. Image-guided tumor ablation has been applied to numerous cancers, including renal cell carcinoma, prostate cancer, lung cancer, and liver cancer with promising short-term results. Radiofrequency ablation has been the most widely studied and utilized ablation modality. However, cryoablation has several relative advantages (most significantly, the ability to produce larger and more precise zones of ablation) over RF ablation and the other heat-based ablation modalities. This manuscript is designed to be an up to date, practical and thorough review of the indications for, techniques of, and patient management issues associated with hepatic cryoablation.

[1]  John M Baust,et al.  Cryoablation of Renal Cancer: Variables Involved in Freezing-Induced Cell Death , 2007, Technology in cancer research & treatment.

[2]  D. Mavroudis,et al.  Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study , 2007, BMC Cancer.

[3]  Michael A. Choti,et al.  Surgical Therapy for Colorectal Metastases to the Liver , 2007, Journal of Gastrointestinal Surgery.

[4]  M. Choi,et al.  Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series , 2007, European Radiology.

[5]  H. Yoshida,et al.  Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers , 2006, Hepatology.

[6]  L. Kavoussi,et al.  Percutaneous computerized tomography guided renal cryoablation using local anesthesia: pain assessment. , 2006, The Journal of urology.

[7]  T. Winter,et al.  Radiofrequency ablation of peripheral liver tumors: intraperitoneal 5% dextrose in water decreases postprocedural pain. , 2006, AJR. American journal of roentgenology.

[8]  P. Burns,et al.  Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography. , 2006, AJR. American journal of roentgenology.

[9]  Xiao-yan Xie,et al.  [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial]. , 2006, Zhonghua yi xue za zhi.

[10]  W. Lau,et al.  A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.

[11]  S. Goldberg,et al.  Characterization of the RF ablation-induced ‘oven effect’: The importance of background tissue thermal conductivity on tissue heating , 2006, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[12]  J. Aparicio,et al.  FOLFOX alternated with FOLFIRI as first-line chemotherapy for metastatic colorectal cancer. , 2005, Clinical colorectal cancer.

[13]  W. Saad,et al.  Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma. , 2005, AJR. American journal of roentgenology.

[14]  L. Kavoussi,et al.  Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation--initial observations. , 2005, Radiology.

[15]  C-J. S. Lin,et al.  Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less , 2005, Gut.

[16]  T. Winter,et al.  Hepatic hemorrhage caused by percutaneous tumor ablation: radiofrequency ablation versus cryoablation in a porcine model. , 2005, Radiology.

[17]  G. Dodd,et al.  Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome. , 2005, AJR. American journal of roentgenology.

[18]  L. Ellis,et al.  Significant Long-Term Survival After Radiofrequency Ablation of Unresectable Hepatocellular Carcinoma in Patients with Cirrhosis , 2005, Annals of Surgical Oncology.

[19]  R. Lencioni,et al.  A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. , 2005, Clinics in liver disease.

[20]  Sammy Saab,et al.  Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation , 2005, Hepatology.

[21]  A. Venook,et al.  The Impact of Pre‐Operative Loco‐Regional Therapy on Outcome After Liver Transplantation for Hepatocellular Carcinoma , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  Y. Duan,et al.  Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. , 2005, Radiology.

[23]  Carlo Bartolozzi,et al.  Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. , 2005, Radiology.

[24]  T. Winter,et al.  Use of dextrose 5% in water instead of saline to protect against inadvertent radiofrequency injuries. , 2005, AJR. American journal of roentgenology.

[25]  S. Monfardini,et al.  FOLFOX versus FOLFIRI: a comparison of regimens in the treatment of colorectal cancer metastases. , 2005, Anticancer research.

[26]  Gerald Antoch,et al.  Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results , 2005, European Radiology.

[27]  C. Bartolozzi,et al.  Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma , 2005, Abdominal Imaging.

[28]  Kemal Tuncali,et al.  Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. , 2004, AJR. American journal of roentgenology.

[29]  M. Kudo,et al.  Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. , 2004, AJR. American journal of roentgenology.

[30]  S. Fan,et al.  Comparison of Systemic Responses of Radiofrequency Ablation, Cryotherapy, and Surgical Resection in a Porcine Liver Model , 2004, Annals of Surgical Oncology.

[31]  L. Niu,et al.  Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma. , 2003, World journal of gastroenterology.

[32]  D. Ott.  Percutaneous radio-frequency liver tumor ablation: what are the risks?: Livraghi T, Solbiati L, Meloni MF, et al., Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441–51 , 2003 .

[33]  T. de Baère,et al.  Adverse events during radiofrequency treatment of 582 hepatic tumors. , 2003, AJR. American journal of roentgenology.

[34]  Luigi Solbiati,et al.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. , 2003, Radiology.

[35]  H. Hussain,et al.  Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: A safe and effective bridge to liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[36]  Ilia S. Zeltser,et al.  Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. , 2002, Journal of endourology.

[37]  P. Petrow,et al.  Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. , 2002, Radiology.

[38]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[39]  C. Bartolozzi,et al.  Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. , 2001, AJR. American journal of roentgenology.

[40]  S. Goldberg,et al.  Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. , 2001, AJR. American journal of roentgenology.

[41]  Gerhard Adam,et al.  MR‐guided percutaneous cryotherapy of the liver: In vivo evaluation with histologic correlation in an animal model , 2001, Journal of magnetic resonance imaging : JMRI.

[42]  D. Morris,et al.  Interleukin-6 and Tumor Necrosis Factor-α Levels following Hepatic Cryotherapy: Association with Volume and Duration of Freezing , 1999, World Journal of Surgery.

[43]  C. Gouillat,et al.  Resection of hepatocellular carcinoma in cirrhotic patients: longterm results of a prospective study. , 1999, Journal of the American College of Surgeons.

[44]  L Solbiati,et al.  Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent--early experience. , 1999, Radiology.

[45]  J. Kuhlman,et al.  CT-monitored percutaneous cryoablation in a pig liver model: pilot study. , 1999, Radiology.

[46]  H. El‐Serag,et al.  Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.

[47]  L Solbiati,et al.  Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. , 1999, Radiology.

[48]  David L. Morris,et al.  World Survey on the Complications of Hepatic and Prostate Cryotherapy , 1999, World Journal of Surgery.

[49]  A. Gage,et al.  Mechanisms of tissue injury in cryosurgery. , 1998, Cryobiology.

[50]  J. Myles,et al.  Renal cryosurgery: experimental evaluation of treatment parameters. , 1998, Urology.

[51]  D. Morris,et al.  Renal impairment in hepatic cryotherapy. , 1998, Cryobiology.

[52]  F. Lee,et al.  Hepatic cryoablation: US monitoring of extent of necrosis in normal pig liver. , 1998, Radiology.

[53]  J. Kuhn,et al.  Cryosurgical ablation of hepatic tumors. , 1997, American journal of surgery.

[54]  B. Eisenberg,et al.  Cryosurgical ablation of hepatic metastases from colorectal carcinomas. , 1997, The American surgeon.

[55]  C. Margarit,et al.  Resection of hepatocellular carcinoma in patients with cirrhosis , 1996, The British journal of surgery.

[56]  S T Wong,et al.  Mr image‐guided control of cryosurgery , 1995, Journal of magnetic resonance imaging : JMRI.

[57]  W. B. Ross,et al.  Cryotherapy of Liver Tumours–A Practical Guide , 1995, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.

[58]  E. Müller‐Schweinitzer.  Arterial Smooth Muscle Function after Prolonged Exposure to a Medium Containing Dimethyl Sulfoxide (Me2SO) and Storage at -196°C , 1994 .

[59]  B. Rubinsky,et al.  Real time ultrasonic monitoring of hepatic cryosurgery. , 1985, Cryobiology.

[60]  B Rubinsky,et al.  Sonographic monitoring of hepatic cryosurgery in an experimental animal model. , 1985, AJR. American journal of roentgenology.

[61]  A A Moss,et al.  Ultrasonic characteristics of frozen liver. , 1984, Cryobiology.

[62]  I. Cooper,et al.  Application of cryogenic surgery to resection of parenchymal organs. , 1966, The New England journal of medicine.